TRT and Heart Health: The New Guidelines for 2026

For over a decade, a dark cloud hung over testosterone replacement therapy: the fear that it caused heart attacks. In 2015, the FDA even mandated a warning label on testosterone products regarding potential cardiovascular risks. This scared off thousands of men and primary care doctors.

But the medical consensus has completely flipped. In 2023, the landmark TRAVERSE Trial—the largest and longest study ever conducted on TRT and heart health—conclusively proved that testosterone therapy does not increase the risk of major adverse cardiovascular events. Here is what you need to know about cardiovascular safety and TRT when working with modern providers like Telehealth FX.

The TRAVERSE Trial Explained

The FDA mandated the TRAVERSE study to settle the debate. They enrolled over 5,200 men aged 45 to 80 who had hypogonadism and pre-existing cardiovascular disease (or high risk factors). This was the highest-risk group imaginable. Half received daily testosterone gel, and half received a placebo.

After nearly three years of tracking, the results published in the New England Journal of Medicine were definitive: the incidence of cardiovascular death, heart attacks, and strokes was statistically identical between the testosterone group and the placebo group. TRT did not harm their hearts.

Low T is the Real Heart Danger

While taking therapeutic doses of testosterone does not hurt the heart, having chronically low testosterone is highly correlated with cardiovascular disease. Hypogonadism is directly linked to:

• Metabolic Syndrome: Increased visceral fat, insulin resistance, and higher triglycerides.
• Endothelial Dysfunction: The inner lining of blood vessels performs poorly in men with low T, increasing arterial stiffness.
• Systemic Inflammation: Low testosterone is associated with higher levels of inflammatory markers like CRP, which damage blood vessels over time.

By restoring testosterone to optimal levels, TRT often improves metabolic profiles, aids in weight loss, and increases exercise capacity—all of which are cardioprotective.

Clinical vs. Abuse Levels

It is vital to distinguish between medical TRT and anabolic steroid abuse. Bodybuilders using 1,000mg to 3,000mg of testosterone a week (alongside synthetic compounds) absolutely suffer severe cardiovascular damage, including left ventricular hypertrophy (heart enlargement).

Medical TRT replaces physiological levels, typically using 100mg to 200mg per week to keep serum levels between 600 and 1000 ng/dL. At these physiological ranges, the heart is safe.